FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between AGS Transact IPO and Supriya Lifescience IPO.
AGS Transact IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Supriya Lifescience IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
AGS Transact IPO | Supriya Lifescience IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Hdfc Bank Limited ICICI Securities Limited Jm Financial Limited |
Axis Capital Limited ICICI Securities Limited |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of AGS Transact IPO is up to ₹680.00 Cr whereas the issue size of the Supriya Lifescience IPO is up to ₹700.00 Cr. The final issue price of AGS Transact IPO is ₹175.00 per share and of Supriya Lifescience IPO is ₹274.00 per share.
AGS Transact IPO | Supriya Lifescience IPO | |
---|---|---|
Face Value | ₹10 per share | ₹2 per share |
Issue Price (Lower) | ₹166.00 per share | ₹265.00 per share |
Issue Price (Upper) | ₹175.00 per share | ₹274.00 per share |
Issue Price (Final) | ₹175.00 per share | ₹274.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 85 shares | 54 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹200.00 Cr | |
OFS Issue Size | ||
OFS Issue Size (Amount) | up to ₹680.00 Cr | up to ₹500.00 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹680.00 Cr | up to ₹700.00 Cr |
AGS Transact IPO opens on Jan 19, 2022, while Supriya Lifescience IPO opens on Dec 16, 2021. The closing date of AGS Transact IPO and Supriya Lifescience IPO is Jan 21, 2022, and Dec 20, 2021, respectively.
AGS Transact IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Jan 19, 2022 | Dec 16, 2021 |
Issue Close | Jan 21, 2022 | Dec 20, 2021 |
Basis Of Allotment (Tentative) | Jan 27, 2022 | Dec 23, 2021 |
Initiation of Refunds (Tentative) | Jan 28, 2022 | Dec 24, 2021 |
Credit of Share (Tentative) | Jan 31, 2022 | Dec 27, 2021 |
Listing date (Tentative) | Jan 31, 2022 | Dec 28, 2021 |
Anchor Lockin End date 1 | Feb 26, 2022 | Jan 22, 2022 |
Anchor Lockin End date 2 | Apr 27, 2022 | Mar 23, 2022 |
AGS Transact IPO P/E ratio is , as compared to Supriya Lifescience IPO P/E ratio of .
AGS Transact IPO | Supriya Lifescience IPO | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 98.23% | 99.98% | ||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 66.07% | 68.24% | ||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹2106.87 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the AGS Transact IPO retail investors (RII) are offered 1,43,37,348 shares while in Supriya Lifescience IPO retail investors are offered 1,43,37,348 shares. Qualified institutional buyers (QIB) are offered 81,92,770 shares in AGS Transact IPO and 79,24,527 shares in Supriya Lifescience IPO.
AGS Transact IPO | Supriya Lifescience IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 81,92,770 shares | 79,24,527 shares |
NII | 61,44,578 shares | 39,62,263 shares |
RII | 1,43,37,348 shares | 26,41,509 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 2,86,74,696 shares | 1,45,28,299 shares |
AGS Transact IPO subscribed 7.79x in total, whereas Supriya Lifescience IPO subscribed 71.51x.
AGS Transact IPO | Supriya Lifescience IPO | |
---|---|---|
QIB (times) | 2.68x | 31.83x |
NII (times) | 25.61x | 161.22x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.08x | 56.01x |
Employee (times) | ||
Other (times) | ||
Total (times) | 7.79x | 71.51x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|